Treatment of rapidly progressing prostatic carcinoma with estracyt.
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use; D004962:Estranes / Q000627:therapeutic use*; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010756:Phosphoric Acids / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D002219:Carbamates; D004962:Estranes; D004967:Estrogens; D009588:Nitrogen Mustard Compounds; D010756:Phosphoric Acids